support@mellalta.com   +1 (304) 306-0723

Diffuse Intrinsic Pontine Glioma (DIPG) -How Aggressive the Disease Pipeline is?

Diffuse Intrinsic Pontine Glioma

Ziopharm Oncology recently received the rare paediatric disease for their gene therapy for Diffuse Intrinsic Pontine Glioma (DIPG). The company has the ability to deliver DNA and stimulate a controlled therapeutic immune response with their […]

Read More

Get In Touch

Let's keep the conversation going